Search

Search Constraints

You searched for: Author/Creator Bardy, Peter

Search Results

2. Australia and New Zealand Transplant and Cellular Therapies (ANZTCT) position statement: COVID‐19 management in patients with haemopoietic stem cell transplant and chimeric antigen receptor T cell. Issue 1 (24th January 2023)

3. Australia and New Zealand Transplant and Cellular Therapies COVID‐19 vaccination consensus position statement. Issue 8 (22nd August 2021)

4. Bone Marrow Transplant Society of Australia and New Zealand COVID‐19 consensus position statement. Issue 6 (14th June 2020)

5. Dynamic assessment of RBC‐transfusion dependency improves the prognostic value of the revised‐IPSS in MDS patients. Issue 6 (20th March 2017)

8. Optimizing antifungal prophylaxis in allogeneic stem cell transplantation: A cohort study of two different approaches. Issue 6 (15th November 2022)

9. The burden of immune‐mediated refractoriness to platelet transfusions in myelodysplastic syndromes. Issue 10 (9th September 2020)

10. The mean fluorescence intensities of anti‐HLA antibodies detected using micro‐bead flow cytometry predict the risk of platelet transfusion refractoriness. (8th May 2013)